Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
University Health Network, Toronto
Immatics US, Inc.
Adaptimmune
Adaptimmune
Adaptimmune
Dana-Farber Cancer Institute
Gilead Sciences
Genocea Biosciences, Inc.
GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline